|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 31/05 | (2013.01) | ||
| A61K 31/122 | (2006.01) | ||
| A61K 31/122 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/14 | (2018.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A23L 33/10 | (2016.08) | ||
| C07C 39/08 | (2013.01) | ||
| C07C 50/02 | (2013.01) | ||
| C07C2601/16 | (2017.05) |
| (11) | Number of the document | 2344142 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09792325.4 |
| Date of filing the European patent application | 2009-09-08 | |
| (97) | Date of publication of the European application | 2011-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/056254 |
| Date | 2009-09-08 |
| (87) | Number | WO 2010/030607 |
| Date | 2010-03-18 |
| (30) | Number | Date | Country code |
| 191696 P | 2008-09-10 | US |
| (72) |
MILLER, Guy, M. , US
KHEIFETS, Viktoria , US
|
| (73) |
PTC Therapeutics, Inc. ,
500 Warren Corporate Center Drive, Warren, NJ 07059,
US
|
| (54) | TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS |
| TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS |